Literature DB >> 6279503

Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta.

H A Singer, M J Peach.   

Abstract

The role of calcium in the relaxations evoked by methacholine and A23187 in intact rabbit aortic rings was investigated. Methacholine (10(-8) to 10(-6) M) and the calcium ionophore A23187 (10(-8) to 10(-6) M) produced dose-dependent relaxations of rings which had been contracted with the alpha-adrenergic agonist phenylephrine. The ability of a ring to relax in this manner was correlated with the presence of endothelium as judged by transmission and scanning electron microscopy. Purposely disrupting the endothelium led to a loss of the relaxation response. In these rings methacholine caused dose-dependent contractions at concentrations greater than 10(-7) M. Deletion of Ca++ from the incubation medium inhibited maximum methacholine-induced relaxations by 67% and A23187-induced relaxations by 92%. The Ca++-channel blockers verapamil (10 microM) and nifedipine (0.5 microM) inhibited maximum methacholine-induced relaxations by 39% and 45%, respectively. The blockers had no effect on the methacholine ED50 (2.5 x 10(-7) M) for relaxation. Verapamil and nifedipine also inhibited maximum A23187-induced relaxations by 43% and 47% with no effect on the ED50 (6 x 19(-8) M) for relaxation. A structurally dissimilar vasodilator, sodium nitroprusside (10(-7) M), had no effect on the A23187-induced relaxation. These data are consistent with a role of Ca++ in regulating either the production or release of endothelial-derived relaxing factor(s).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279503

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  Inhibition by quinine of endothelium-dependent relaxation of rabbit aortic strips.

Authors:  D Gebremedhin; P Hadházy; K Magyar
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Endothelium-dependent calcium-induced relaxation in the presence of Ca2+-antagonists in canine depolarized coronary arteries.

Authors:  K Kikkawa; S Murata; T Nagao
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.

Authors:  C J Weir; I F Gibson; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

5.  Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists.

Authors:  G Weinheimer; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

6.  Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.

Authors:  K W Buchan; W Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

7.  Voltage-activated potassium, but not calcium currents in cultured bovine aortic endothelial cells.

Authors:  K Takeda; V Schini; H Stoeckel
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

8.  Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)

Authors:  T Saito; A Wolf; N K Menon; M Saeed; C Alves; R J Bing
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Role of GTP-protein and endothelium in contraction induced by ethanol in pig coronary artery.

Authors:  M Kuroiwa; H Aoki; S Kobayashi; J Nishimura; H Kanaide
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

10.  Bradykinin induces elevations of cytosolic calcium through mobilisation of intracellular and extracellular pools in bovine aortic endothelial cells.

Authors:  K W Buchan; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.